These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35073553)

  • 1. Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia.
    Ahmed S; Odumade OA; van Zalm P; Smolen KK; Fujimura K; Muntel J; Rotunno MS; Winston AB; Steen JA; Parad RB; Van Marter LJ; Kourembanas S; Steen H
    Neonatology; 2022; 119(2):193-203. PubMed ID: 35073553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics-Based Mapping of Bronchopulmonary Dysplasia-Associated Changes in Noninvasively Accessible Oral Secretions.
    Ahmed S; Odumade OA; van Zalm P; Fatou B; Hansen R; Martin CR; Angelidou A; Steen H
    J Pediatr; 2024 Jul; 270():113774. PubMed ID: 37839510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia.
    Kindt ASD; Förster KM; Cochius-den Otter SCM; Flemmer AW; Hauck SM; Flatley A; Kamphuis J; Karrasch S; Behr J; Franz A; Härtel C; Krumsiek J; Tibboel D; Hilgendorff A
    Pediatr Res; 2023 Feb; 93(3):625-632. PubMed ID: 35595912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease.
    Fanos V; Pintus MC; Lussu M; Atzori L; Noto A; Stronati M; Guimaraes H; Marcialis MA; Rocha G; Moretti C; Papoff P; Lacerenza S; Puddu S; Giuffrè M; Serraino F; Mussap M; Corsello G
    J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():39-45. PubMed ID: 25284176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 6. Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia.
    Yılmaz C; Köksal N; Özkan H; Dorum BA; Bağcı O
    Turk J Pediatr; 2017; 59(2):122-129. PubMed ID: 29276864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics.
    Piersigilli F; Lam TT; Vernocchi P; Quagliariello A; Putignani L; Aghai ZH; Bhandari V
    Metabolomics; 2019 Feb; 15(2):20. PubMed ID: 30830433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia.
    Alvarez-Fuente M; Moreno L; Lopez-Ortego P; Arruza L; Avila-Alvarez A; Muro M; Gutierrez E; Zozaya C; Sanchez-Helguera G; Elorza D; Martinez-Ramas A; Villar G; Labrandero C; Martinez L; Casado T; Cuadrado I; Del Cerro MJ
    PLoS One; 2019; 14(3):e0213210. PubMed ID: 30840669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
    PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the natural history of bronchopulmonary dysplasia from proteomics and multiplexed immunohistochemistry.
    Dylag AM; Misra RS; Bandyopadhyay G; Poole C; Huyck HL; Jehrio MG; Haak J; Deutsch GH; Dvorak C; Olson HM; Paurus V; Katzman PJ; Woo J; Purkerson JM; Adkins JN; Mariani TJ; Clair GC; Pryhuber GS
    Am J Physiol Lung Cell Mol Physiol; 2023 Oct; 325(4):L419-L433. PubMed ID: 37489262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased volume of tracheal aspirate fluid predicts the development of bronchopulmonary dysplasia.
    Iwatani S; Mizobuchi M; Tanaka S; Inomata K; Sakai H; Yoshimoto S; Nakao H
    Early Hum Dev; 2013 Feb; 89(2):113-7. PubMed ID: 22980969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium signaling-related proteins are associated with broncho-pulmonary dysplasia progression.
    Magagnotti C; Matassa PG; Bachi A; Vendettuoli V; Fermo I; Colnaghi MR; Carletti RM; Mercadante D; Fattore E; Mosca F; Andolfo A
    J Proteomics; 2013 Dec; 94():401-12. PubMed ID: 24140977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].
    Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715
    [No Abstract]   [Full Text] [Related]  

  • 14. Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age?
    Lodha A; Ediger K; Rabi Y; Lodha S; Tang S; Bhandari A; Sauve R; Bhandari V
    J Perinatol; 2015 Jul; 35(7):530-6. PubMed ID: 25719546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease.
    Voynow JA; Fisher K; Sunday ME; Cotten CM; Hamvas A; Hendricks-Muñoz KD; Poindexter BB; Pryhuber GS; Ren CL; Ryan RM; Sharp JK; Young SP; Zhang H; Greenberg RG; Herring AH; Davis SD
    Pediatr Pulmonol; 2020 Apr; 55(4):899-908. PubMed ID: 31995668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants.
    Balena-Borneman J; Ambalavanan N; Tiwari HK; Griffin RL; Halloran B; Askenazi D
    Pediatr Res; 2017 Mar; 81(3):519-525. PubMed ID: 27893721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia.
    Gaio P; Verlato G; Daverio M; Cavicchiolo ME; Nardo D; Pasinato A; de Terlizzi F; Baraldi E
    Clin Nutr ESPEN; 2018 Feb; 23():234-239. PubMed ID: 29460805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracheal aspirate cytology and bronchopulmonary dysplasia.
    Rothberg AD; Miot A; Leiman G
    Diagn Cytopathol; 1986 Sep; 2(3):212-6. PubMed ID: 3769730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracheal Aspirate Levels of the Matricellular Protein SPARC Predict Development of Bronchopulmonary Dysplasia.
    Popova AP; Cui TX; Kaciroti N; Goldsmith AM; Linn MJ; Pryhuber GS; Hershenson MB
    PLoS One; 2015; 10(12):e0144122. PubMed ID: 26656750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.